$AFFX (Affymetrix Inc.)

$AFFX {{ '2016-03-24T15:33:39+0000' | timeago}} • Announcement

Biotechnology company $AFFX said its BoD has informed Origin Technologies Corporation that it will engage in discussions with Origin regarding its unsolicited merger proposal submitted on March 22, 2016 to acquire $AFFX for $17.00 per share in an all-cash transaction. There can be no assurance as to the outcome of any discussions with Origin.

$GE {{ '2017-07-21T18:59:39+0000' | timeago}} • Webcast

John Flannery, who is to be $GE's 13th CEO effective Aug 1, 2017, brushed aside concerns that the company might find itself in a state of limbo during the transition period. He said there is no operational paralysis within the team, adding robust discussions will happen in November regarding the future of course of $GE's operations.

$GE {{ '2017-07-21T18:13:06+0000' | timeago}} • Webcast

$GE reiterated its FY17 net earnings guidance of $1.60-1.70 per share on organic sales growth, which is expected in the range of 3-5%. The company added that EPS is trending to the bottom end of the projected range, as Oil and Gas continues to witness weakness.

$GE {{ '2017-07-21T17:28:46+0000' | timeago}} • Webcast

Cash flow from operations, one of $GE's closely watched financial metric, plummeted 67% to $3.6Bil in 2Q17. The Boston, Massachusetts-based conglomerate said this was primarily due to the sale of its appliances division.

$GE {{ '2017-07-21T12:51:53+0000' | timeago}} • Infographic

$GE General Electric Earnings AlphaGraphics: Q2 2017 highlights

$GE {{ '2017-07-21T11:43:55+0000' | timeago}} • Announcement

$GE CEO Jeff Immelt said, "We expect cash flow to continue to improve throughout the year. We’ve reduced our industrial structural costs year-to-date by $670MM and we are on track to meet or exceed our $1Bil cost reduction target for the year."

$GE {{ '2017-07-21T11:40:52+0000' | timeago}} • Announcement

Primarily due to $GE's shift of focus into industrial operations, its backlog in 2Q17 grew 2% to $327Bil, while orders increased 6% to $28.3Bil. $GE has a history of orders and backlogs growing faster than its revenue.

$GE {{ '2017-07-21T11:38:01+0000' | timeago}} • Announcement

$GE's total revenue in 2Q17 fell 12% to $29.6Bil due to weakness in its Energy Connections segment, which supplies automation products to various industries including marine, mining and oil & gas. Revenue from this segment fell 27% during the quarter.

$GE {{ '2017-07-21T11:35:13+0000' | timeago}} • Announcement

In 2Q17, which marks the end of Jeff Immelt at the helm of $GE after 16 years, the multinational conglomerate posted net earnings that more-than-halved to $1.19Bil, or $0.13 per share. On a non-GAAP basis, EPS declined 45% to $0.28 during the quarter.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$NEM {{ '2017-07-19T20:55:03+0000' | timeago}} • Announcement

$NEM elected Sheri Hickok and Molly Zhang to its BoD. Hickok is currently General Manager, Global Product Development, Onshore Wind at $GE's Renewable Energy. Zhang currently serves as a director of Cooper Standard Automotive and XG Science as a supervisory board member at GEA Group in Germany.

$BDX {{ '2017-07-19T13:58:34+0000' | timeago}} • Announcement

$BDX received 510(k) clearance from the FDA for the BD FACSLyric flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitest assays for immunological assessment of individuals and patients having or suspected of having immune deficiency.

$TMO {{ '2017-07-19T12:44:47+0000' | timeago}} • Announcement

$TMO priced an offering of EUR2.6Bil of senior notes. The issuance of the notes is expected to close on or about July 24, 2017. $TMO plans to use all of net proceeds to fund a portion of consideration payable for its acquisition of Patheon, including the repayment of debt of Patheon to be assumed by $TMO, which is estimated to be about $7.2Bil.

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$MSFT {{ '2017-07-18T12:18:43+0000' | timeago}} • Announcement

Kate Johnson to join $MSFT as President and Corporate VP of Microsoft US on Sept 8, 2017. Johnson currently serves as Chief Commercial Officer of GE Digital, a unit of $GE.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

Recent Transcripts

GE (General Electric Company)
Friday, July 21 2017 - 12:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
UQM (UQM Technologies Inc.)
Thursday, May 11 2017 - 8:30pm
HOLX (Hologic Inc.)
Wednesday, May 10 2017 - 8:30pm
COHR (Coherent Inc.)
Tuesday, May 9 2017 - 8:30pm
PKI (PerkinElmer Inc.)
Thursday, May 4 2017 - 9:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
CBMX (CombiMatrix Corporation)
Thursday, May 4 2017 - 8:30pm
PSDV (pSivida Corp.)
Thursday, May 4 2017 - 8:30pm
BDX (Becton, Dickinson and Company)
Thursday, May 4 2017 - 12:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
BRKR (Bruker Corporation)
Wednesday, May 3 2017 - 8:45pm
QGEN (Qiagen NV)
Wednesday, May 3 2017 - 1:00pm
TECH (Bio-Techne Corp.)
Tuesday, May 2 2017 - 1:00pm
XYL (Xylem Inc.)
Tuesday, May 2 2017 - 1:00pm
BDX (Becton, Dickinson and Company)
Tuesday, May 2 2017 - 12:00pm
STS (Supreme Industries Inc.)
Monday, May 1 2017 - 1:00pm
SNE (Sony Corporation)
Friday, April 28 2017 - 8:15am
PACB (Pacific Biosciences of California, Inc.)
Wednesday, April 26 2017 - 8:30pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, April 26 2017 - 12:30pm

AlphaGraphics you may like